Email this article Intravenous high-dose immunotherapy: practical recommendations for use in the treatment of neurological disimmune diseases
- Authors: Suponeva N.A.1, Grishina D.A.1
-
Affiliations:
- Research Center of Neurology, 80 Volokolamskoe Shosse, Moscow, 125367, Russia
- Issue: Vol 5, No 4 (2015)
- Pages: 16-23
- Section: LECTURES AND REVIEWS
- Published: 16.12.2015
- URL: https://nmb.abvpress.ru/jour/article/view/128
- DOI: https://doi.org/10.17650/2222-8721-2015-5-4-16-23
- ID: 128
Cite item
Full Text
Abstract
Current publication summarizes main indications and benefits of intravenous high-dose immunotherapy (IHI) in the treatment of various autoimmune diseases of the peripheral nervous system. Available products of intravenous immunoglobulin (IVIG) on the Russian market are reviewed. Tactics for choosing optimal medication for IHI based on its effectiveness and safety are analyzed. Dosage calculation and way of administration of IVIG are described, beeing of a high practical value in neurologist’s daily work.
About the authors
N. A. Suponeva
Research Center of Neurology, 80 Volokolamskoe Shosse, Moscow, 125367, Russia
Author for correspondence.
Email: nasu2709@mail.ru
Russian Federation
D. A. Grishina
Research Center of Neurology, 80 Volokolamskoe Shosse, Moscow, 125367, Russia
Email: fake@neicon.ru
Russian Federation
References
Supplementary files
